Extracellular matrix deficiency contributes to irregular uterine bleeding following progestin therapy for adenomyosis
Reduced extracellular matrix and collagen levels in adenomyosis endometrium correlate with irregular bleeding during progestin therapy, suggesting matrix metalloproteinase inhibition or collagen supplementation as potential preventative treatments.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Adenomyosis in Pregnancy: Diagnostic Pearls and Pitfalls via openalex
- Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components via openalex
- Expression deregulation of matrix metalloproteinases and vasoconstriction related genes in Pakistani females with abnormal uterine bleeding via openalex
- Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis via openalex
- Physiology of the Endometrium and Regulation of Menstruation via openalex
- Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest via openalex
- Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis via openalex
- Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients via openalex
- Treatment of symptomatic adenomyosis with the levonorgestrel‐releasing intrauterine system via openalex
- W4225647505 via openalex
- W4243033733 via openalex
- W4283331795 via openalex
- W4387582329 via openalex
- W4387640260 via openalex
- W1894268419 via openalex
- W4394981881 via openalex
- W1990653503 via openalex
- W1994589849 via openalex
- W2015375238 via openalex
- W2026781892 via openalex
- W2151389753 via openalex
- W2508704093 via openalex
- W2790094279 via openalex
- W3109752137 via openalex
SciLite annotations
chemicals 6
organisms 1
Source provenance
- europepmc
- last seen: 2026-08-30T09:23:35.175841+00:00
- openalex
- last seen: 2026-08-30T06:00:46.221890+00:00
- pubmed
- last seen: 2026-08-30T06:02:44.349700+00:00
- scilite
- last seen: 2026-08-02T09:40:10.667495+00:00
Courtesy of the U.S. National Library of Medicine